Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.34 | 0.3 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.06 |